פמוזול

البلد: إسرائيل

اللغة: العبرية

المصدر: Ministry of Health

العنصر النشط:

LETROZOLE 2.5 MG

متاح من:

PERRIGO ISRAEL AGENCIES LTD

ATC رمز:

L02BG04

الشكل الصيدلاني:

FILM COATED TABLETS

طريقة التعاطي:

PER OS

المصنعة من قبل:

HAUPT PHARMA MUNSTER GmbH, GERMANY

المجموعة العلاجية:

LETROZOLE

الخصائص العلاجية:

• Femozol (letrozole tablets) is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer . • Femozol is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy .• Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy .• Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer .

تاريخ الترخيص:

2010-11-01